Takeda submits NDA in the US for ixazomib for the treatment of multiple myeloma
15 July 2015 | By Victoria White
Takeda has submitted an NDA to the US FDA for ixazomib for the treatment of patients with relapsed and/or refractory multiple myeloma...
List view / Grid view
News
Mylan and Dr Reddy’s launch Memantine hydrochloride tablets in the US
15 July 2015 | By Victoria White
Both Mylan and Dr. Reddy's have launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, which is the generic version of Namenda Tablets, in the US...
Celgene to acquire Receptos for $7.2 billion
15 July 2015 | By Victoria White
Celgene and Receptos have signed a definitive agreement in which Celgene has agreed to acquire Receptos for approximately $7.2 billion...
Lilly Diabetes launches Android version of Glucagon Mobile app
15 July 2015 | By Victoria White
Lilly has released an Android version of its Glucagon Mobile application designed for caregivers and healthcare providers who support people with diabetes...
Quotient Clinical announces expansion of pharmaceutical sciences capacity
14 July 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced a significant expansion of its pharmaceutical sciences capabilities...
Digital evolution for ground-breaking Yellow Card Scheme
14 July 2015 | By Victoria White
Fifty years on from its inception, the UK Yellow Card Scheme is moving into the digital age through a free-access mobile app...
Soliris could drive myasthenia gravis treatment market value beyond $550 million by 2024, says GlobalData
14 July 2015 | By Victoria White
The global market for myasthenia gravis therapeutics is anticipated to more than treble in value from $146.4 million in 2014 to $550.4 million by 2024...
EU approves Gadovist for use in paediatric patients less than 2 years of age
14 July 2015 | By Victoria White
Bayer's Gadovist has received a label extension in the EU for diagnostic use with MRI or MRA in paediatric patients less than 2 years of age...
Sanofi Pasteur ships first 2015-2016 seasonal influenza vaccine doses in US
14 July 2015 | By Victoria White
The FDA has released the first doses of Sanofi Pasteur’s Fluzone influenza vaccine for shipment for the 2015-2016 influenza season in the US...
Quotient Clinical acquires second GMP manufacturing facility
14 July 2015 | By Victoria White
Quotient Clinical is to expand its pharmaceutical sciences capabilities. This includes the acquisition of a second GMP manufacturing facility...
Ferrer initiates Phase IIa clinical study of Lorediplon in patients with insomnia
14 July 2015 | By Victoria White
The first patient has been recruited into a Phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in insomnia...
FDA approves Iressa for first-line treatment of patients with a type of metastatic lung cancer
14 July 2015 | By Victoria White
The FDA has approved Iressa for the first-line treatment of patients with NSCLC whose tumours have EGFR exon 19 deletions or exon 21 substitution mutations...
pSivida announces positive top-line results from investigator-sponsored Phase II study of Medidur in uveitis
13 July 2015 | By Victoria White
pSivida has announced positive top-line results from a Phase II investigator-sponsored study of Medidur for uveitis affecting the posterior of the eye...
Anacor’s crisaborole achieves primary and secondary endpoints in two Phase 3 studies in eczema
13 July 2015 | By Victoria White
Anacor has announced positive preliminary top-line results from its two Phase 3 pivotal studies of crisaborole in atopic dermatitis (eczema)...
Yusen Logistics expands air freight forwarding operations in Mexico
Yusen Logistics (Mexico) S.A. DE C.V. opened two offices inside and outside at the Mexico City Airport on June 1. By establishing a base on the airport front lines to manage its own air transportation operations, the company aims to realize competitive freight procurement and detailed transportation management of imported…
